The Ministry of Health, through the Pharmacy and Poisons Board, has banned the trading, importing, or handling of any unregistered products, particularly those with references to the Indian Pharmacopeia.
In a statement to newsrooms, the Board says the Indian Pharmacopeia is not duly registered to operate in Kenya.
“The Indian Pharmacopeia is NOT within the purview of drug registration requirements in the country, and as such, products citing this standard are not compliant with Kenyan regulations,” Dr. Fred M. Siyoi, the Chief Executive Officer (CEO) of the Board says.
Dr Siyoi is further urging all stakeholders to adhere to the requirements outlined in the Pharmacy and Poisons Act and any other relevant regulations.
“TAKE NOTICE THAT, failure to comply with this directive will attract severe regulatory actions, including but not limited to: Seizure of products, Revocation of licenses and Prosecution as stipulated under the law,” the Board adds.
The Board vows to continue monitoring the market and take necessary enforcement actions to ensure compliance with the applicable regulatory framework.
